4 ML golimumab 12.5 MG/ML Injection [Simponi]

Known as: golimumab 50 mg in 4 mL INTRAVENOUS SOLUTION [SIMPONI ARIA], Simponi Aria 50 MG per 4 ML Injection, 4 ML Simponi 12.5 MG/ML Injection 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Golimumab (Simponi®), a fully human monoclonal antibody against tumour necrosis factor-alpha (TNFα), is given once monthly by… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2014
Review
2014
The introduction of therapeutic antibodies against tumor necrosis factor (TNF) had a major impact on the treatment of ulcerative… (More)
  • table 1
  • table 3
  • table 2
  • table 4
Is this relevant?
Review
2013
Review
2013
 
Is this relevant?
2009
2009
The annular Poiseuille flow a Newtonian fluid is studied assuming that slip occurs along the walls. Different slip models… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 8
Is this relevant?